Frontiers in Neurology (Sep 2022)

The pharmacological treatment of acute vestibular syndrome

  • Pasquale Viola,
  • Federico Maria Gioacchini,
  • Alessia Astorina,
  • Davide Pisani,
  • Alfonso Scarpa,
  • Gianmarco Marcianò,
  • Alessandro Casarella,
  • Emanuele Basile,
  • Vincenzo Rania,
  • Massimo Re,
  • Giuseppe Chiarella

DOI
https://doi.org/10.3389/fneur.2022.999112
Journal volume & issue
Vol. 13

Abstract

Read online

Acute vestibular syndrome (AVS) represents a clinical picture that involves urgent management due to the important procession of symptoms accompanying the event, which can be positively or negatively influenced by therapeutic choices and intervention timing. This forces a differential diagnosis and therapeutic choices to be made in conditions that are not always favorable and often not in the specialist field. In this work, we will examine in detail the pharmacological therapeutic possibilities, correlating them to the differential and, as far as possible, to the etiological diagnosis. In particular, the pharmacological possibilities for the two main conditions we can face will be investigated, namely, vestibular neuritis and posterior circulation stroke.

Keywords